Sio Capital Management as of Dec. 31, 2025
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 68 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celcuity (CELC) | 7.5 | $48M | 477k | 99.74 | |
| Cigna Corp (CI) | 7.5 | $47M | 172k | 275.23 | |
| Sanofi Sa Sponsored Adr (SNY) | 7.4 | $47M | 972k | 48.46 | |
| Maximus (MMS) | 6.8 | $43M | 500k | 86.32 | |
| Zimmer Holdings (ZBH) | 5.5 | $35M | 386k | 89.92 | |
| Rhythm Pharmaceuticals Put Option (RYTM) | 4.5 | $28M | 266k | 107.04 | |
| Kenvue (KVUE) | 4.0 | $25M | 1.5M | 17.25 | |
| Organon & Co Common Stock (OGN) | 3.9 | $25M | 3.4M | 7.17 | |
| Icon SHS (ICLR) | 3.6 | $23M | 127k | 182.22 | |
| Waystar Holding Corp (WAY) | 3.2 | $20M | 614k | 32.75 | |
| Livanova SHS (LIVN) | 3.1 | $20M | 322k | 61.53 | |
| Dianthus Therapeutics (DNTH) | 3.1 | $20M | 475k | 41.21 | |
| Biohaven (BHVN) | 2.2 | $14M | 1.2M | 11.29 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.2 | $14M | 202k | 69.55 | |
| BioMarin Pharmaceutical (BMRN) | 2.2 | $14M | 233k | 59.43 | |
| Tyra Biosciences (TYRA) | 2.2 | $14M | 526k | 26.29 | |
| Brightspring Health Svcs (BTSG) | 1.8 | $12M | 308k | 37.45 | |
| Centene Corporation (CNC) | 1.8 | $11M | 274k | 41.15 | |
| Charles River Laboratories (CRL) | 1.7 | $11M | 55k | 199.48 | |
| Teleflex Incorporated (TFX) | 1.7 | $11M | 87k | 122.04 | |
| Anteris Technologies Global (AVR) | 1.5 | $9.4M | 1.9M | 4.99 | |
| Protara Therapeutics Com Stk (TARA) | 1.4 | $9.1M | 1.7M | 5.33 | |
| Cross Country Healthcare (CCRN) | 1.4 | $8.7M | 1.1M | 8.10 | |
| Haemonetics Corporation (HAE) | 1.2 | $7.4M | 93k | 80.15 | |
| Biosante Pharmaceuticals (ANIP) | 1.1 | $6.9M | 87k | 78.94 | |
| Aquestive Therapeutics (AQST) | 1.0 | $6.4M | 993k | 6.46 | |
| Bright Minds Biosciences Com New (DRUG) | 1.0 | $6.4M | 82k | 78.04 | |
| Edgewise Therapeutics (EWTX) | 0.9 | $5.9M | 238k | 24.82 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.9 | $5.8M | 43k | 134.85 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.9 | $5.8M | 125k | 46.55 | |
| Rapport Therapeutics (RAPP) | 0.9 | $5.6M | 185k | 30.34 | |
| AmerisourceBergen (COR) | 0.8 | $5.4M | 16k | 337.75 | |
| McKesson Corporation (MCK) | 0.8 | $5.2M | 6.4k | 820.29 | |
| Disc Medicine (IRON) | 0.7 | $4.6M | 58k | 79.41 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.7 | $4.4M | 2.2M | 2.02 | |
| Fulcrum Therapeutics (FULC) | 0.7 | $4.3M | 382k | 11.31 | |
| Savara (SVRA) | 0.6 | $3.7M | 614k | 6.03 | |
| Oruka Therapeutics (ORKA) | 0.6 | $3.6M | 118k | 30.31 | |
| Ventyx Biosciences (VTYX) | 0.6 | $3.5M | 388k | 9.03 | |
| Pmv Pharmaceuticals (PMVP) | 0.5 | $3.3M | 2.6M | 1.25 | |
| Shoulder Innovations Common Stock (SI) | 0.5 | $3.3M | 228k | 14.30 | |
| Aligos Therapeutics Com New (ALGS) | 0.5 | $3.1M | 336k | 9.32 | |
| Vir Biotechnology (VIR) | 0.5 | $2.9M | 478k | 6.03 | |
| Alkermes SHS (ALKS) | 0.4 | $2.7M | 95k | 27.98 | |
| Ideaya Biosciences (IDYA) | 0.4 | $2.6M | 76k | 34.57 | |
| Kymera Therapeutics (KYMR) | 0.4 | $2.5M | 32k | 77.81 | |
| Elicio Therapeutics Put Option (ELTX) | 0.4 | $2.4M | 297k | 7.96 | |
| Ovid Therapeutics (OVID) | 0.4 | $2.3M | 1.4M | 1.63 | |
| Context Therapeutics (CNTX) | 0.3 | $2.0M | 1.3M | 1.47 | |
| Hyperfine Com Cl A (HYPR) | 0.3 | $2.0M | 2.0M | 0.98 | |
| Outlook Therapeutics Put Option (OTLK) | 0.3 | $1.8M | 1.1M | 1.58 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.3 | $1.6M | 131k | 12.52 | |
| Ibio Com New (IBIO) | 0.2 | $1.4M | 740k | 1.93 | |
| Xilio Therapeutics (XLO) | 0.2 | $1.4M | 2.1M | 0.64 | |
| Adagio Med Hldgs (ADGM) | 0.2 | $1.3M | 1.3M | 1.04 | |
| Avalo Therapeutics Com New (AVTX) | 0.2 | $1.3M | 72k | 18.16 | |
| Neuroone Med Technologies Com New (NMTC) | 0.1 | $864k | 1.1M | 0.76 | |
| Tela Bio (TELA) | 0.1 | $751k | 636k | 1.18 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $664k | 123k | 5.40 | |
| Senseonics Hldgs (SENS) | 0.1 | $639k | 116k | 5.52 | |
| Enanta Pharmaceuticals (ENTA) | 0.1 | $631k | 40k | 15.77 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $408k | 10k | 40.40 | |
| Modular Med Com New (MODD) | 0.0 | $286k | 786k | 0.36 | |
| Nyxoah S A SHS (NYXH) | 0.0 | $234k | 51k | 4.60 | |
| Boundless Bio (BOLD) | 0.0 | $196k | 164k | 1.20 | |
| Nextcure Com New (NXTC) | 0.0 | $155k | 11k | 14.19 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $7.2k | 400k | 0.02 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $4.9k | 50k | 0.10 |